Bodisen Biotech Inc
23 November 2007


Bodisen Biotech, Inc. reports Unaudited Third Quarter Financial Results

Review & Extracts of the Form10-Q as required by the Securities & Exchange Commission

Results of Operations

Revenue.
We generated revenues of $10,494,694 for the nine months ended
September 30, 2007, a decrease of $29,136,072 or 73.5%, compared to $39,630,766 for the nine months ended September 30, 2006. The significant decrease in revenue was due to the decline in our customer base, which decreased following our delisting from the Amex and, to a lesser extent, the abnormally cold Spring time weather of Shaanxi province as well as a storm and drought in the third quarter of 2007, all of which affected crop plantings and decreased the use of fertilizer.

Gross Profit.
We achieved a gross profit of $4,618,129 for the nine months ended September 30, 2007, a decrease of $10,903,912 or 70.2%, compared to $15,522,041 for the nine months ended September 30, 2006. The significant decrease in gross profit was due to the significant decrease in revenue as result of decreased sales, and, to a lesser extent, increased commodities prices which increased our costs of revenues. Gross margin (gross profit as a percentage of revenues), increased, from 39.2% for the nine months ended September 30, 2006, to 44.0% for the nine months ended September 30, 2007 primarily due to changes in overall product mix comprising sales.

Operating expenses. We incurred operating expenses of $6,699,732 for the nine
months ended September 30, 2007, an increase of $2,990,489 or 80.6% compared to
$3,709,243 for the nine months ended September 30, 2006. The significant
increase in our operating expenses is related to legal fees associated with
litigation and other matters in connection with the Amex delisting and a loss of
approximately $1,700,000 due to storm damage in August 2007.

Aggregated selling expenses accounted for $1,276,208 of our operating expenses
for the nine months ended September 30, 2007, a decrease of $427,400 or 25.1%
compared to $1,703,608 for the nine months ended September 30, 2006. The
decrease in our aggregated selling expenses is primarily due the reduction in
transportation costs, which continued to be negatively affected by the continued
increases in petroleum prices. The reduction in our transportation costs was
partially offset by increased labor costs. General and administrative expenses
accounted for the remainder of our operating expenses of $5,423,524 for the nine
months ended September 30, 2007, which increased $3,417,889 or 170.4% compared
to $2,005,635 for the nine months ended September 30, 2006. The significant
increase in our general and administrative expenses is primarily related to
legal fees associated with litigation and other matters in connection with the
Amex delisting and a loss of approximately $1,700,000 due to storm damage in
August 2007.

Non Operating Income and Expenses. We had total non-operating income of
$258,820 for the nine months ended September 30, 2007 compared to total
non-operating expense of $60,432 for the nine months ended September 30, 2006.
We had other expense of $143 for the nine months ended September 30, 2007
compared to other income of $500,604 for nine months ended September 30,2006.
In 2006, other income was due to the effects of a foreign currency transaction
gain, which we did not have in 2007. Total non-operating income includes
interest income of $262,870 for the nine months ended September 30, 2007
compared to only $118,129 of interest income for the nine months ended September 30, 2006. The increase in interest income for the nine months ended September 30, 2007 is due to the full year effects of the increased cash balance that resulted from our sale of stock in the first quarter of 2006. Total non-operating income for the nine months ended September 30, 2007 also includes interest expense of only $3,907 compared to $679,165 for the nine months ended September 30, 2006. The majority of the interest expense in the nine months ended September 30, 2006 relates to the $5 million note issued December 8, 2005, which was repaid during March 2006.

Net Income (Loss). For the foregoing reasons, we had a net loss of $1,822,783
for the nine months ended September 30, 2007, a decrease of $13,575,149 or
115.5% compared to net income of $11,752,366 for the nine months ended September 30, 2006. We had earnings (loss) per share of $(0.10) for the nine months ended September 30, 2007 compared to earnings per share of $0.66 for the nine months ended September 30, 2006.

I totally agree, halifax